INCORPORATION OF AZOBENZENES INTO DNA
CONFIRMATION THAT AZOBENZENE PORTFOLIO IS INCLUDED IN DNA.
DNA SYNTHESIS
Dissolve the dried compound 3 (250 mg, 0.307 mmol) in dry AN (3.1 ml) in a vial (the concentration of compound 3 is approximately 0.1 M). With this amount of compound 3 , approximately 3 X residues can be incorporated through the DNAsynthesizer using a synthesis program of 0.2 m mol scale.
Equip the DNA synthesizer with the vial containing the solution of compound 3 as well as with vials of solutions ofconventional dA, dG, dC and dT phosphoramidite monomers.
Set the 3’-Dabcyl-CPG support (for Dabcyl-DNA) or dT-CPG, C6-NH2-CPG on the DNA synthesizer and start the synthesis at a scale of 0.2 mmol.
Stop the DNA synthesis; do not remove the DMT group at the 5'-terminal. Full-length DNA with the X insert will thus have been synthesized on the CPG support.
DEPROTECT AND PURIFICATION
Transfer the CPG support to a vial and add 500µl AMA.
It was heated at 65˚C for 10 mins for the deprotection of phosphate group and nucleic acid base and cleavage from the CPG support at the same time.
Added Nacl 500µl (100mg/ml)
Flushed the glen-Pak cartridge with 1ml 2 M TEAA.
Loaded the DNA solution onto the cartridge. Collect the eluted fraction
Flushed the glen-Pak cartridge with1ml sample
Flushed the glen-Pak cartridge with1ml Salt wash solution (100mg/mL Nacl in 5% AN)
Detritylated the support-bound DNA by flushing the cartridge with 1ml 2% TFA solution twice.
Flushed the glen-Pak cartridge with 1ml mQ water.
Eluted the purified, detritylated DNA by flushing the cartridge with 50% AN.
Removed the solvent using a vacuum dryer.
After simple purification using NAP column and evaporation of solvent.
IDENTIFICATION AND PURIFICATION
Characterize the sample by MALDI-TOFMS of the DNA solution using 1:1water/AN solution of 3-hydroxypicolinic acid and 0.5 M diammonium hydrogen citrate solution as a matrix.
Purify the stock solution by HPLC.
Characterize the sample by MALDI-TOFMS of the DNA solution using 1:1water/AN solution of 3-hydroxypicolinic acid and 0.5 M diammonium hydrogen citrate solution as a matrix.
STAPLE DNA INCORPORATED INTO TIRES
DNA SYNTHESIS
Transfer the CPG support to a vial and add 500µl AMA.
Dissolve the dried compound 3 (250 mg, 0.307 mmol) in dry AN (3.1 ml) in a vial (the concentration of compound 3 is approximately 0.1 M). With this amount of compound 3 , approximately 4 X residues can be incorporated through the DNAsynthesizer using a synthesis program of 0.2 m mol scale.
Equip the DNA synthesizer with the vial containing the solution of compound 3 as well as with vials of solutions ofconventional dA, dG, dC and dT phosphoramidite monomers.
Set the 3’-Dabcyl-CPG support (for Dabcyl-DNA) or dT-CPG, dC-CPG, dT-CPG, dA-CPG on the DNA synthesizer and start the synthesis at a scale of 0.2 mmol.
Stop the DNA synthesis; do not remove the DMT group at the 5'-terminal. Full-length DNA with the X insert will thus have been synthesized on the CPG support.
DEPROTECT AND PURIFICATION
It was heated at 65℃for 10 mins for the deprotection of phosphate group and nucleic acid base and cleavage from the CPG support at the same time.
Added Nacl 500µl (100mg/ml)
Flushed the glen-Pak cartridge with 1ml 2 M TEAA.
Loaded the DNA solution onto the cartridge. Collect the eluted fraction
Flushed the glen-Pak cartridge with1ml sample
Flushed the glen-Pak cartridge with1ml Salt wash solution (100mg/mL Nacl in 5% AN)
Detritylated the support-bound DNA by flushing the cartridge with 1ml 2% TFA solution twice.
Flushed the glen-Pak cartridge with 1ml mQ water.
Eluted the purified, detritylated DNA by flushing the cartridge with 50% AN.
Removed the solvent using a vacuum dryer.
After simple purification using NAP column and evaporation of solvent.
IDENTIFICATION AND PURIFICATION
Characterize the sample by MALDI-TOFMS of the DNA solution using 1:1water/AN solution of 3-hydroxypicolinic acid and 0.5 M diammonium hydrogen citrate solution as a matrix.
Purify the stock solution by HPLC.
Characterize the sample by MALDI-TOFMS of the DNA solution using 1:1water/AN solution of 3-hydroxypicolinic acid and 0.5 M diammonium hydrogen citrate solution as a matrix.